PR Newswire
DALLAS , Sept. 7, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that Jody Staggs , President and Interim CEO of SWK Holdings, will participate in Lake Street Capital's 6 th Annual Best Ideas Growth Conference "BIG6" being held September 14, 2022 in New York City .
During the conference, Mr. Staggs will conduct one-on-one meetings with registered investors, showcasing SWK Holdings' business and investment strategy, recent corporate achievements, and anticipated milestones.
Details of the conference are as follows:
Event : Lake Street Capital's 6th Annual Best Ideas Growth Conference "BIG6"
Date: September 14, 2022
Location: The Yale Club, 50 Vanderbilt Ave, New York, NY
About SWK Holdings CorporationSWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. SWK provides non-dilutive financing to fuel the development and commercialization of life-saving and life-enhancing medical technologies and products. SWK's unique financing structures provide flexible financing solutions at an attractive cost of capital to create long-term value for all SWK stakeholders. SWK's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases, and typically range in size from $5.0 million to $25.0 million . SWK also owns Enteris BioPharma, whose Peptelligence ® and ProPerma ® drug delivery technologies create oral formulations of peptide-based and BCS class II, III, and IV small molecules. With Enteris, SWK has the opportunity to grow its finance portfolio by actively creating a wholly-owned portfolio of milestones and royalties through licensing activities. Additional information on the life science finance market is available on the Company's website at www.swkhold.com .
SOURCE SWK Holdings Corporation